269 Evaluating Outcomes of Feeding Jejunostomy Tubes in Oesophago-Gastric Resection Patients: A Single Tertiary Centre Experience

Abstract Aim Enteral nutrition via jejunostomy tubes remains a critical component of perioperative care in oesophago-gastric (OG) cancer patients. While national practices vary, the NOGCA 2020 guidelines recommend selective use, particularly in high-risk patients or those undergoing neoadjuvant therapy. The purpose of this study is to evaluate the outcomes on basis of type and timing of Feeding jejunostomy tube. Method We conducted a retrospective review of patients undergoing OG resections at our institution (2023–2024). Data analysis included type of resection, type of tube used (Freka vs MIC) and comparison of groups with and without tube placement. The primary outcome variable was adverse outcome in either group. Results Out of a total of 84 patients undergoing oesophageal (57) resection and gastric resection (27), 50 patients (59.5%) had a tube placement. 18 patients in the tubed group (36.73%) developed complications with the most common ones being infection, leakage, blockage, and dislodgement. Freka tubes placed intra-operatively, were associated with fewer issues compared to MIC tubes. Conclusions Feeding Jejunostomy tubes are effective in selected high-risk patients. Timing and method of placement affect outcomes. Feeding jejunostomy tube improve nutritional recovery with planned tube placement. National OG Cancer Audit cautions against blanket placement. Improving documentation and multidisciplinary nutritional planning remain essential. These findings support national guidance for individualised, evidence-based decision-making in enteral access following OG surgery. Further prospective randomised control studies are warranted to establish superiority of the type and timing of Feeding Jejunostomy tube.